Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Granules gets USFDA nod for postpartum haemorrhage prevention drug

17 May, 2018 5:28 AM
50 0
Granules gets USFDA nod for postpartum haemorrhage prevention drug

Drug firm Granules India today said its subsidiary has received approval from the US health regulator for Methylergonovine tablets, used for the prevention and control of postpartum haemorrhage.

In a filing to BSE, Granules India said "the U S Food and Drug Administration (USFDA) has approved its abbreviated new drug applications (ANDA) for Methylergonovine 0.2 mg tablets. The ANDA was filed by Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India Ltd".

The approved product is the bioequivalent to the reference listed drug product Methergine 0.2 mg, it added.

Source: moneycontrol.com

Share in social networks:

Comments - 0